🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥Hot off the press American Cancer Society 2022 Cancer Facts & Figures for Black people, highlighting alarming #disparities. Risk of #Cancer death for Black individuals 19% higher for men & 12% higher for women compared to White individuals. 👉pressroom.cancer.org/CFFAABP#.Ygbx3…

Beautifully said Neelima Denduluri “Be patient and collaborative. Share successes and credit with your colleagues, because we rise together. There is a lot of work to be done to improve health care globally, and we cannot do it alone.” #bcsm #mentoring

Marcia's #lymphedema caused her leg to become so swollen that she couldn't walk properly. Find out how Dr. David H. Song (DAVID H SONG MD, MBA 송하빈), performed a lymph node transfer and got her running again. bit.ly/3oAUt5j

In the April 15 issue: Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant. bit.ly/3vecEl1

Looking forward to seeing these data and how they transform our #bcsm patients’ journey! #ESMOBreast22

In June 2020, an issue of JCO was published, including the first data of T-DXd in HER2-low MBC & the first review on this entity (ascopubs.org/doi/abs/10.120…) 2 years later, the positive ph3 data of T-DXd in HER2-low MBC will be presented at #ASCO22, confirming the HER2-low paradigm

Invited to a destination wedding earlier in Apr. Awesome place that holds a special place in my ❤️(Vail). Lots of people I miss. All #vaxxed. Many boosted. No masks required. No rapid tests. Declined. One positive couple next AM. Groom & all but 4 guests got #COVID19. #pandemic

Really interesting results presented by @prat_aleix at #ESMOBreast22. 45% of patients with HR+/HER2- early #breastcancer respond to just 1 cycle of neoadjuvant #PatritumabDeruxtecan.

PROs from Destiny-Breast03 presented by G Curigliano MD PhD QOL maintained with T-DXd and delayed time to deterioration of pain symptoms, and delayed first hospitalization #ESMOBreast22 OncoAlert

PHERGain: selection of best cut-off for prediction of pCR prediction in HER2+ pts not recv'ing chemo (ie. HP) Increased deltaSUV (≥77%) after 2 cycles of HP achieves pCR similar to chemo +HP Original cut-off of delta SUV 40% spares the most pts chemo OncoAlert #ESMOBreast22

As an onc i find hardest to care for women w children-gives a special impetus to push our limits. Thinking today abt how we could do more to ensure these children could celebrate Mother's day with their loved one for many yrs to come. We're making progress- but much more to do!

Expectations for #ESMOBreast22 were high, but they were ultimately widely exceeded! Great in-person and virtual attendance, important new data & brilliant educationals made of this congress a terrific experience. Here’s my #top10 (+ bonus) Take Home Messages from #ESMOBreast22

Out on NPJ Breast a new report on #ERlowtumors. No difference in characteristics, pCR rates, RFS os OS compared with #TNBC. Patients with ER-low tumors should be treated as for TNBC. Also, important confounder to remember in HER2-low prognostic analyses. nature.com/articles/s4152…

Tuesday, 9/13 from 10-11:30 a.m. and 1-3:40 p.m. the Kids Mobile Medical Clinic will be located at Walker-Jones Education Campus (1125 New Jersey Ave NW) to provide FREE back-to-school vaccines, including the COVID-19 vaccines, to all children ages 6 mo. and up.

Do you know a single mom with MBC in the US Northeast that is in financial distress? Refer them to Infinite Strength and Roberta Lombardi for financial assistance! #bcsm

What will we do Monday morning? My take home points from #SABCS22 - limiting and oversimplifying an incredible amount of high-quality research to fit in a few slides OncoAlert #bcsm SABCS

On this episode of our #DocTalk #podcast, medical oncologist Dr. Claudine Isaacs discusses innovations in treating #BreastCancer, the different types of breast cancer, and more. To listen, visit spoti.fi/40GUaad.

Obesity is not the problem. None of our young CRC patients is obese. They are better described as marathon running, cardboard eating healthy contributing citizens. We must think differently, and I suspect our microbiome is hiding answers. bit.ly/3EPg4Ps The Washington Post

In this Special Communication, three strategies are proposed to make cancer drugs more accessible and affordable in low- and middle-income countries. ja.ma/3UQ29Ay

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update 🔹️No routine SLNB in postmenopausal, ≥50 y/o, grade 1-2, ≤2 cm, HR+, HER2- BC with neg axillary US + BCS 🔹️PMRT + RNI may be offered, ALND omitted in clinically node-neg, ≤5 cm BC with